What is the Project?
Biosyncaucho’s project objective is the development of high value added chemical products from renewable raw materials. Incorporated in May 2015 under Tecnalia’s strategic vision, Biosyncaucho was born with a strong commitment in the field of energy and the environment. TECNALIA Research & Innovation transferred intangible assets and a cash contribution to form Biosyncaucho S.L., which is owned by TECNALIA and a private equity fund, Kereon Partners. This collaboration, with sponsorship from the Omega Fund managed by Tecnalia Ventures, nurtures a unique blend of science and market insight – all to develop natural biomolecules derived from non-alimentary, renewable resources…
Main Benefits
The project offers remarkable benefits that are clear from its structure and approach, including:
- High added value chemical products produced from renewable raw materials
- A proprietary fermentation process ensuring biomolecules are developed with low Carbon Footprint
- Collaboration between strong institutional players like TECNALIA, Kereon Partners, and the Omega Fund
- Robust support from various stakeholders including financial investors, industrial partners, and smart capital agents
- A new Business Unit under the commercial denomination Biokemik, reinforcing market recognition
Investment Opportunities
Investment opportunities include a diverse range of potential contributors such as Investors (Financial) who are agents wishing to support Biokemik as a growth, scalable company with high internationalization potential. Customers, too, are a crucial part of the venture, as potential clients are invited to validate the biomolecules for either single or multiple applications. Additionally, Licensees are companies that can acquire an independent license to use the biomolecules, while Industrial Partners are welcomed to support the final stages of BD development, scale-up, and industrialize the products. Even agents in the value chain who bring fresh, innovative business models can become part of this sustainable endeavor by providing access to channels and final customers.
An Overview of the Products
The portfolio is both innovative and diverse. For example, Bio-1,3-Butadiene is produced using a new, proprietary fermentation process from renewable biomass. This product, addressing the worldwide butadiene shortage, is designed not only to supply valuable intermediates but also to unlock multiple applications such as thermoplastic elastomers, nylon, fine chemicals, synthetic rubber, styrenic plastics, and epoxy resins. Then there is Bio-2,3-Butanediol, a biobased product that offers a cleaner and more competitive alternative to its synthetic counterpart. It boasts applications that span across plastics (PU, polyester, and NIPU), pesticides, chemicals, pharmaceutical compounds, and beyond.
Commercial and Industrial Aspects
Bio-Methyl-Ethyl-Ketone (MEK) serves as a universal solvent with significant market potential. Its low viscosity, high evaporation rate, and miscibility with hydrocarbons make it appealing for various industrial applications ranging from paints and coatings to epoxy, acrylic, polyester, and even pharmaceutical use. Alongside this, Bio-Acetoin emerges as a specialty chemical serving as a platform for further innovation. Employed as a fine chemical and specialty additive, acetoin finds its uses in food flavoring, diacetyl precursor applications, fragrances, and even cigarette additives. All these products exemplify a commitment to innovation, safety, and environmental responsibility…
Technical and Commercial Integration
The project integrates technical expertise with commercial potential seamlessly. Each product in the portfolio follows a meticulous design process that identifies specific industrial applications, ensuring that the products not only meet market demands but also bring added value to their end uses. The approach taken in product development is dynamic and engaging; it continuously evolves, taking into account real-life industrial needs and prospective applications. Even as development nears the final stages – the last mile of BD development for instance – the process is constantly refined to keep up with changing market dynamics and technological progress.
Project Impact
- SDG 7: Affordable and Clean Energy – through using renewable raw materials
- SDG 9: Industry, Innovation, and Infrastructure – thanks to the pioneering fermentation and process technologies
- SDG 12: Responsible Consumption and Production – by promoting high-added value products with low Carbon Footprint
- SDG 13: Climate Action – through the commitment to renewable resources and sustainable chemical production
Future Prospects
The project’s future surely looks promising… Biosyncaucho, operating under Biokemik, is not just solving today’s challenges such as shortages and environmental impact, but it is also laying the foundation for a breakthrough in chemical production using renewable resources. Combining robust investment opportunities with a sustainable products portfolio, Biosyncaucho continues to drive innovation, setting new benchmarks for efficient, safe, and environmentally responsible chemical production. The collaborative spirit that fuels the venture ensures that every step forward not only meets industrial and commercial needs but also contributes toward a greener and smarter future for the chemical industry. Through focused partnerships and a commitment to technological excellence, the project paves the way for a market that values both profitable growth and sustainable industrial practices – truly a win-win scenario for industry, investors, and the planet.
